Cantor Fitzgerald is set to launch a $3 billion Bitcoin investment initiative in collaboration with SoftBank, Tether, and Bitfinex, according to a report by the Financial Times. The project ...

On Wednesday, Cantor Fitzgerald reiterated an Overweight rating on shares of Summit Therapeutics plc (NASDAQ:SMMT), following the company’s recent clinical trial updates. The company ...

Cantor Fitzgerald, SoftBank Group, Tether, and Bitfinex have joined hands to launch Twenty One. The consortium of traditional finance (TradFi) and decentralized finance (DeFi) firms announced on ...

Brandon Lutnick, chair of investment banking firm Cantor Fitzgerald, is reportedly partnering with SoftBank, Tether and Bitfinex to create a $3 billion crypto acquisition company. Lutnick and the ...

Bond brokerage Cantor Fitzgerald, stablecoin giant Tether and SoftBank Group are teaming up to launch Twenty One Capital, a bitcoin accumulation vehicle aimed at Wall Street institutions.

Brandon Lutnick, chairman of Cantor Fitzgerald and son of U.S. Commerce Secretary Howard Lutnick, is leading a significant Bitcoin investment initiative. The venture will operate under a new ...

SoftBank, Tether, and Cantor Fitzgerald are in talks on a $3B public vehicle built around a bitcoin treasury strategy. SoftBank, one of Japan’s most powerful corporate institutions, is reportedly in ...

Cantor Fitzgerald is reportedly preparing to launch a multibillion-dollar Bitcoin investment vehicle in partnership with SoftBank, Tether and Bitfinex, as institutional interest in digital assets ...

Tuesday, shares of Vaxcyte (NASDAQ:PCVX) received a new Overweight rating from Cantor Fitzgerald as the firm initiated coverage on the biotechnology company. The decision comes after Vaxcyte ...

Cantor Fitzgerald, the financial services firm formerly led by U.S. commerce secretary Howard Lutnick, is the latest company to enter into the Bitcoin acquisition business. The company ...

Cantor Fitzgerald analysts paint a grim picture for equity markets (SP500), (COMP:IND), (DJI), pointing to significantly slowing economic growth, inflated earnings estimates, and potential shocks ...

On Wednesday, Cantor Fitzgerald reiterated an Overweight rating on shares of Summit Therapeutics plc (NASDAQ:SMMT), following the company’s recent clinical trial updates. The company, now valued at ...